SLNO icon

Soleno Therapeutics
SLNO

Overview Fund Trends Analyst Outlook Journalist POV

22 hedge funds and large institutions have $5.23M invested in Soleno Therapeutics in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 13 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

77% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 13

86% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 21

Holders
22
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$37K
Puts
$24K
Net Calls
Net Calls Change

Top Buyers

1
+$167K
2
+$75K
3
+$13.8K
4
Morgan Stanley
Morgan Stanley
New York
+$1K
5
TRCT
Tower Research Capital (TRC)
New York
+$719

Top Sellers

1
-$394K
2
-$55K
3
-$43K
4
NCM
Nantahala Capital Management
Connecticut
-$41.6K
5
Two Sigma Investments
Two Sigma Investments
New York
-$28K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
–
27
–
28
–
29
–
30
–
31
–
32
–
33
–
34
–
35
–
36
–
1
2